南非西开普省基层医疗华法林治疗TTR研究
该回顾性横断面分析纳入南非西开普省公共基层医疗2018至2022年全部华法林治疗患者,用Rosendaal法计算TTR(治疗目标范围2.0-3.0)。
要点
- 83.2%的基层华法林患者TTR≤65.0%,中位TTR仅37.7%。
- 仅5.0%患者依从且稳定,该亚组中位TTR为30.0%。
- 年轻、更频繁INR监测和更多住院与依从及TTR≤65.0%显著相关。
核心结论
- 南非西开普省基层医疗华法林抗凝控制不理想,中位TTR低,需改进患者管理策略并考虑华法林替代方案。
研究设计与样本
- 回顾性横断面分析,使用2018-01-01至2022-12-31西开普省公共基层医疗全部华法林治疗患者的常规数据,不限定诊断。
主要发现
- 83.2%患者TTR≤65.0%,中位(IQR)TTR为37.7%(16.9%-56.9%)。
- 仅5.0%患者被归类为依从且稳定,该亚组中位(IQR)TTR为30.0%(7.7%-54.2%)。
- 年轻、更频繁INR监测和更多住院与依从本身及TTR≤65.0%均显著相关。
- 首次达到治疗范围INR的中位(IQR)时间为57(27-141)天,但用Rosendaal法计算时更低。
临床怎么用
- 基层华法林管理应加强INR监测频率与依从性干预,以改善TTR。
- 鉴于中位TTR低,临床可考虑华法林以外的抗凝替代方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Warfarin therapy is the mainstay of anticoagulation treatment in South Africa and requires frequent INR monitoring due to interindividual patient variability. Time in therapeutic range (TTR) reflects the proportion of total treatment time during which INR values are within therapeutic range. This study determined the TTR for warfarin-treated patients in South African provincial primary healthcare (PHC) facilities over a 5-year period METHODS: This retrospective cross-sectional analysis used routine data from all patients on warfarin therapy regardless of diagnosis attending PHC facilities in the Western Cape public healthcare sector, from 2018-01-01 to 2022-12-31. TTR, calculated using the Rosendaal method, was assessed using a therapeutic range of 2.0-3.0. Adherence was measured using dispensing data. RESULTS: Among 20 342 patients on warfarin, TTR could be calculated for 15 371 patients, with 83.2% of patients having suboptimal TTR of ≤65.0% and median (IQR) TTR of 37.7% (16.9%-56.9%). Only 5.0% of patients were classified as adherent and stabilized on warfarin with a median (IQR) TTR of 30.0% (7.7%-54.2%) in this subset. Younger age, more frequent INR monitoring and more hospital admissions were significantly associated with both adherence itself, and with TTR ≤65.0%. Median (IQR) time to first therapeutic INR was 57 (27-141) days but was lower when calculated using the Rosendaal method. CONCLUSION: We found suboptimal anticoagulation control in a South African PHC setting which requires strategies for improved patient care. Given the low median TTR, alternatives to warfarin should be considered.
引用
- Paleker M, Kelly C, Dyers R, et al. Warfarin time in therapeutic range of primary healthcare patients in the Western Cape Province, South Africa. Br J Clin Pharmacol. 2026. PMID: 42604756. doi:10.1002/bcp.70727
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。